FDA Inspection 1317938 — Chemo Biosynthesis s.r.l.
The FDA completed an inspection of Chemo Biosynthesis s.r.l. on February 5, 2026 in Corana. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 5, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Corana (Italy)
Additional Details
Mutual Recognition Agreement (MRA)